Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jason R Fangusaro
Pediatric Brain Tumor Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- National Institutes of Health Clinical Center
Bethesda, Maryland, United States
- National Cancer Institute
Rockville, Maryland, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Saint Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jul 2015
- Primary completion
- 1 Jul 2019
- Completion
- 27 May 2020
- Last update posted
- 25 Apr 2022
- Registered enrollment
- 29
- Registry id
- NCT02415153
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.